Patent classifications
C07C233/66
Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, compositions containing such molecules, and processes of using such molecules and compositions against such pests. These molecules and compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (Formula One). ##STR00001##
Process for preparing biphenylamines from anilides by ruthenium catalysis
The present invention relates to a novel process for preparing substituted biphenylamides of the general formula (V) ##STR00001##
characterized in that
anilides of the formula (II) ##STR00002##
in a solvent other than tetrahydrofuran,
are reacted with an organoboron compound of the formula (III) ##STR00003##
in the presence of a catalyst system consisting of a ruthenium catalyst, an activator, an oxidizing agent and a metal triflate.
Process for preparing biphenylamines from anilides by ruthenium catalysis
The present invention relates to a novel process for preparing substituted biphenylamides of the general formula (V) ##STR00001##
characterized in that
anilides of the formula (II) ##STR00002##
in a solvent other than tetrahydrofuran,
are reacted with an organoboron compound of the formula (III) ##STR00003##
in the presence of a catalyst system consisting of a ruthenium catalyst, an activator, an oxidizing agent and a metal triflate.
Process for preparing biphenylamines from anilides by ruthenium catalysis
The present invention relates to a novel process for preparing substituted biphenylamides of the general formula (V) ##STR00001## characterized in that anilides of the formula (II) ##STR00002## in a solvent other than tetrahydrofuran, are reacted with an organoboron compound of the formula (III) ##STR00003## in the presence of a catalyst system consisting of a ruthenium catalyst, an activator, an oxidizing agent and a metal triflate.
Process for preparing biphenylamines from anilides by ruthenium catalysis
The present invention relates to a novel process for preparing substituted biphenylamides of the general formula (V) ##STR00001## characterized in that anilides of the formula (II) ##STR00002## in a solvent other than tetrahydrofuran, are reacted with an organoboron compound of the formula (III) ##STR00003## in the presence of a catalyst system consisting of a ruthenium catalyst, an activator, an oxidizing agent and a metal triflate.
FUNCTIONALIZED BENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION
Pharmaceutical compositions of the invention comprise functionalized benzamide derivatives useful as pregenomic RNA encapsidation inhibitors, useful for the treatment of Hepatitis B virus (HBV) infection.
FUNCTIONALIZED BENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION
Pharmaceutical compositions of the invention comprise functionalized benzamide derivatives useful as pregenomic RNA encapsidation inhibitors, useful for the treatment of Hepatitis B virus (HBV) infection.
IMMUNOREGULATORY AGENTS
Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
Benzamides-containing compounds and their use in the treatment of epilepsy
The present invention is directed to benzamide-containing compounds of formula I ##STR00001##
or pharmaceutically acceptable salts thereof which inhibit the P2X.sub.7 receptor, and their use in the treatment of epilepsy.
Benzamides-containing compounds and their use in the treatment of epilepsy
The present invention is directed to benzamide-containing compounds of formula I ##STR00001##
or pharmaceutically acceptable salts thereof which inhibit the P2X.sub.7 receptor, and their use in the treatment of epilepsy.